by Leon et al. in 2010 (1) , the field of interventional cardiology has witnessed a revolution in minimally invasive cardiovascular care. Rigorous studies have substantiated its use in an increasingly wider array of patients, and the U.S. Food and Drug Administration recently approved the first large prospective randomized trial of transcatheter aortic valve replacement (TAVR) in low-risk patients. It is becoming more and more important to predict, a priori, which patients will benefit with which TAVR strategies, and imaging is best positioned to make this possible.
Two-dimensional and 3-dimensional echocardiography and cardiovascular computed tomography angiography (CTA) have become essential diagnostic components in the evaluation of patients who may be candidates for TAVR, during the TAVR procedure itself, and for follow-up after TAVR. CTA is visually superior in imaging complex anatomy, while echocardiography is superior in temporal resolution and ease of imaging; however, they remain complementary, with some unique niche roles (2) . CTA has essentially displaced echocardiography for sizing the aortic valve. In addition, many relatively novel The authors have reported that they have no relationships relevant to the contents of this paper to disclose. (4) did not specify the point within the cardiac cycle at which they measured angulation. Their illustrative frames do not appear to be in an end-systolic phase.
Given the 3-dimensional actuation of the ventricle during systole, which includes torsion, it is expected that aortoventricular angle measurements may be dependent on the time within the cardiac cycle.
Second, the methods of TAVR themselves were different between the 2 studies. In the study by Popma et al. (5) , an aortoventricular angle of 70 or less was a requisite for a transfemoral or left subclavian approach, while a right subclavian approach was deemed necessary for aortoventricular angles <30 .
In contrast, in the single-center experience of Abramowitz et al. (4), it appears that these access protocols were not mandatory and may represent a more "real-world" experience.
Third, and of equal importance, the units of analysis were markedly different between the 2 studies.
In the case of Popma et al. (5) 
Editor's Page A U G U S T 2 0 1 6 : 1 0 1 9 -2 1 logically yet be a situation in which aortic angle might influence device outcomes. In the interest of good patient care, our work is never done, and constant evaluation and analysis are the only way to improve outcomes.
One lesson learned from these 2 studies is that the details matter. Seemingly minor differences in methodology can generate major controversies.
Differences in study design, procedural methodology, and statistical analyses can engender marked differences in study findings. As imagers, we can take a lesson from the playbook of our colleagues in interventional cardiology, who at a very early stage had standardized definitions for clinical outcomes and procedural success. In contrast, we as imagers have not generally taken this approach. This deficiency is highlighted in the 2 studies in this issue of iJACC wherein a systematic approach with a start point in the coronal view will inevitably result in confusing findings that can be statistically analyzed but not practically implemented. Given the slew of new transcatheter structural heart disease technologies that are emerging, including transcatheter mitral valve replacement (which will be much more complex in 3-dimensional anatomy) and others, it would be wise for multimodality imagers to rigorously implement standardized image evaluation and reporting protocols so that the results can be generalized to the whole of the field.
